According to Emergen Research, the global human microbiome therapeutics market size was USD 296.46 million in 2020 and is expected to reach USD 1,340.04 million in 2028 and register a revenue CAGR of 22.0% during the forecast period, 2021-2028.
Emergen Research has published its latest report titled “Human Microbiome Therapeutics Market, By Product Type (Prescription Drugs, Probiotics, Prebiotics, Medical Foods), By Approach (Microbial Consortia, Phage Cocktail, Small Molecule Therapies, Microbial Ecosystems, Genetically Modified Single Strain Bacteria, Single Strain Whole Bacteria), By Therapeutic Area (Oncology, Autoimmune Disorders, Dermatological Disorders, Metabolic Disorders, Infectious Disease, Others), By Disease Type (Crohn’s Disease, Irritable Bowel Syndrome, Clostridium Difficile Colitis, Diabetes, Others), By Technology (Genomics, Proteomics, Metabolomics, Others), and By Region Forecast to 2028”
According to Emergen Research, the global human microbiome therapeutics market size was USD 296.46 million in 2020 and is expected to reach USD 1,340.04 million in 2028 and register a revenue CAGR of 22.0% during the forecast period, 2021-2028.
Market Dynamics:
Revenue growth of the global human microbiome therapeutics market is substantially driven by factors including growing prevalence of digestive & metabolic disorders, infectious diseases, autoimmune disorders, and oncological disorders worldwide, increasing applications of human microbiome in personalized medicine and nutritional supplements, rising awareness of health & wellness, and growing awareness of drug-related adverse health effects. Human microbiome refers to a diverse range of microorganisms such as bacteria, fungi, viruses, and other microbes present in the body that play an integral role in various metabolic, immunologic, and hormonal functions.
Human microbiome increases the efficacy of specific therapeutic compounds and is beneficial for treatment of various diseases. Hence, increasing focus on novel drug discovery and development, technological advancements in proteomics and metagenomics, and rise in R&D collaborations between leading pharmaceutical companies and research organizations for more advanced and effective human microbiome therapeutics are the other key factors supporting the global human microbiome therapeutics market revenue growth.
Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/280
COVID-19 Impact Analysis:
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Probiotics Segment Accounted for Largest Revenue Share in 2020:
Based on product type, the global human microbiome therapeutics market is segmented into Prescription Drugs, Probiotics, Prebiotics, and Medical Foods. The probiotics segment was the most dominant in terms of largest revenue share in the global market in 2020. Changing lifestyles and eating habits, rising incidences of digestive and metabolic disorders across the globe, growing use of probiotics (healthy gut bacteria) in formulation of medicines and nutritional products, and increasing R&D activities for advanced human microbiome therapeutics are key factors driving revenue growth of this segment.
Infectious Disease Segment to Account for Fastest Revenue CAGR:
Based on disease type, the global human microbiome therapeutics market is segmented into Oncology, Autoimmune Disorders, Dermatological Disorders, Metabolic Disorders, Infectious Disease, and Others. The infectious disease segment is expected to register the fastest revenue CAGR in the global market over the forecast period, owing to many favorable factors. Rising cases of infectious diseases worldwide, increasing incidences of antibiotic or anti-viral drug side-effects, growing use of human microbiome therapeutics in treatment of infectious disease, and rise in R&D projects and clinical trials of new microbiome-based therapies are among the major factors supporting this segment’s growth.
North America Accounted for Largest Revenue Share in 2020:
Among regional markets, the North America human microbiome therapeutics market accounted for the largest revenue share in the global market in 2020. Growing geriatric population, rising prevalence of chronic and acute diseases, increasing consumption of nutritional supplements, growing rising demand for precision medicine, and increased spending on healthcare products are key factors driving the regional market revenue growth. Increasing government investments in pharmaceutical and biotechnological research & development projects and presence of major market players in the region, including Vedanta BioSciences, ViThera Pharmaceuticals, Seres Therapeutics, and Synlogic, further boost the North America market growth.
Looking for Discount [Click on the link] @ https://www.emergenresearch.com/request-discount/280
Major Companies in the Global Human Microbiome Therapeutics Market Include:
- Seres Therapeutics
- ViThera Pharmaceuticals
- Vedanta BioSciences
- Second Genome
- Synlogic
- Oxidien Pharmaceuticals, LLC
- BiomX Ltd.
- LNC Therapeutics SA
- Commense Inc.
- Embion Technologies SA
- DermBiont, Inc.
- CoreBiome, Inc.
- Carbiotix AB
- Biotagenics Inc.
- Finch Therapeutics
For the purpose of this report, Emergen Research has segmented the global human microbiome therapeutics market based on product type, approach, therapeutic area, disease type, technology, and region:
Product Type Outlook (Revenue, USD Million; 2018-2028)
- Prescription Drugs
- Prebiotics
- Probiotics
- Medical Foods
Approach Outlook (Revenue, USD Million; 2018-2028)
- Microbial Consortia
- Phage Cocktail
- Small Molecule Therapies
- Microbial Ecosystems
- Genetically Modified Single Strain Bacteria
- Single Strain Whole Bacteria
Therapeutic Area Outlook (Revenue, USD Million; 2018-2028)
- Oncology
- Autoimmune Disorders
- Infectious Disease
- Dermatological Disorders
- Metabolic Disorders
- Others
Disease Type Outlook (Revenue, USD Million; 2018-2028)
- Crohn’s Disease
- Irritable Bowel Syndrome
- Clostridium Difficile Colitis
- Diabetes
- Others
Technology Outlook (Revenue, USD Million; 2018-2028)
- Genomics
- Proteomics
- Metabolomics
- Others
Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/human-microbiome-therapeutics-market
Region Outlook (Revenue, USD Million; 2018-2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of Middle East & Africa
Explore Related Reports by Emergen Research:
The global metaverse in finance market size was significantly robust in 2020 and is expected to register rapidly inclining revenue CAGR over the forecast period. Rapid adoption of metaverse initiatives by brokerage companies and banks to improve the business offerings, emergence of cryptocurrency as a large-scale alternative financial system, and growing focus of fintech and smaller financial companies on developing their own digital financial ecosystems are key factors expected to drive market revenue growth over the forecast period.
The global metaverse in healthcare market size was significantly robust in 2020 and is expected to register a rapid revenue CAGR over the forecast period. Some key factors driving steady market revenue growth include integration of Augmented Reality (AR), Virtual Reality (VR), and Artificial Intelligence (AI) in the healthcare sector to improve efficiency of medical equipment, enable provision of hands-on training to personnel, and diagnose and treat certain conditions.
The global metaverse in automotive market size was significantly robust in 2020 and is expected to register a rapid revenue CAGR over the forecast period. Growing focus on leveraging metaverse technology in car to create human machine interface, emerging opportunities for contextual advertising for automotive dealers, rising trend of online car buying, and increasing efforts undertaken by major automotive companies to develop their own metaverse platforms are some key factors expected to fuel market revenue growth over the forecast period.
The global metaverse in gaming market size was significantly robust in 2020 and is expected to register a rapidly inclining CAGR during the forecast period. Rapidly rising popularity of play-to-earn games, increasing efforts to create immersive gaming experiences, and growing investment to develop different versions of metaverse are some key factors expected to drive market revenue growth over the forecast period.
The global digital water market size reached USD 7.96 Billion in 2020 and is expected to register a revenue CAGR of 12.1% during the forecast period. Increasing need for better water services is resulting in growing demand for digital water services, which is a major factor expected to drive market revenue growth over the forecast period.
The global Computer-Generated Imagery (CGI) market size reached USD 3.18 Billion in 2020 and is expected to register a revenue CAGR of 19.9% during the forecast period. Increasing demand for more cost-effective animation tools and increasing need to improve brand credibility are some of the key factors expected to continue to drive global computer-generated imagery market revenue growth during the forecast period.
The global emerging memory technologies market size reached USD 4.17 Billion in 2020 and is expected to register a revenue CAGR of 30.7% during the forecast period. Increasing demand for high-end and more advanced devices and increasing need for time saving in data transferring are some of the key factors expected to continue to drive global emerging memory technologies market revenue growth during the forecast period.
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read Full Press Release@ https://www.emergenresearch.com/press-release/global-human-microbiome-therapeutics-market